SpringWorks (SWTX) | Stock Overview & Key Data
SpringWorks Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $96.48 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Mar 31, 2025
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SpringWorks
SWTX
|
3.54B Mid-cap | 0.04% | 0.69% | 27.03% | 27.03% | 27.03% | 27.79% | 61.20% | 22.37% | 107.64% | 107.64% | 107.64% |
|
Vertex
VRTX
|
109.45B Large-cap | -2.03% | -0.35% | -9.68% | -7.51% | -5.26% | 1.24% | 34.08% | 113.19% | 376.31% | 717.28% | 1,190.86% |
|
Regeneron
REGN
|
80.98B Large-cap | -1.40% | -12.73% | -19.27% | -14.47% | -20.27% | 25.39% | -16.92% | 20.10% | 53.41% | 959.24% | 4,557.42% |
|
BridgeBio Pharma
BBIO
|
14.21B Large-cap | -1.44% | -5.09% | 1.47% | -11.69% | -16.31% | 93.46% | 364.66% | 14.32% | 145.68% | 145.68% | 145.68% |
|
Blueprint Medicines
BPMC
|
8.37B Mid-cap | 0.12% | 1.05% | 53.79% | 61.42% | 61.42% | 12.60% | 149.54% | 73.38% | 370.76% | 598.65% | 598.65% |
|
Bio-Techne
TECH
|
9.07B Mid-cap | 5.74% | -7.11% | -10.77% | -20.32% | -14.75% | 6.78% | -37.73% | -51.28% | 86.91% | 161.27% | 281.12% |
Ownership & Short Interest
Calculate Your SpringWorks Investment Returns
Long-Term Investment Performance Analysis
SpringWorks stock price in Sep 2019 was $22.63, A $1,000.00 lump sum investment in SpringWorks made 5 years ago would be worth approximately $2,076.45 today, representing a strong return of 107.64%. This translates to an annualized return (CAGR) of 13.39%.
5 Years 9 Months Investment Scenario (Sep 2019 - Jul 2025)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SWTX's 52-week high and low?
- In the last 52 weeks, SpringWorks reached a high of $62.00 (on February 20, 2025) and a low of $28.21 (on October 24, 2024).
- What is the market cap and P/E ratio for SWTX?
- Curious about SpringWorks's size and valuation? Its market capitalization stands at 3.54B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -21.96.
- Does SWTX pay dividends? If so, what's the yield?
- As for dividends, SpringWorks isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are SpringWorks's main competitors or similar companies to consider before investing?
When looking at SpringWorks, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX109.45B Healthcare Biotechnology 1.24% 34.08% Regeneron
REGN80.98B Healthcare Biotechnology 25.39% -16.92% BridgeBio Pharma
BBIO14.21B Healthcare Biotechnology 93.46% 364.66% Blueprint Medicines
BPMC8.37B Healthcare Biotechnology 12.60% 149.54% Bio-Techne
TECH9.07B Healthcare Biotechnology 6.78% -37.73% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for SpringWorks Therapeutics, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of SpringWorks's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -51.57%, the Debt to Equity ratio from the most recent quarter is 1.77, and its Gross Profit Margin stands at 92.81%.
- What is the recent revenue and earnings growth for SWTX?
- Looking at SpringWorks's growth, its revenue over the trailing twelve months (TTM) was $220M. Compared to the same quarter last year (YoY), quarterly revenue grew by 133.70%, and quarterly earnings saw a YoY growth of 133.68%.
- How much of SWTX stock is held by insiders and institutions?
- Wondering who owns SpringWorks stock? Company insiders (like executives and directors) hold about 1.28% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 87.40%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.